Inventor

ANDREA MAHR

Inventor

DE

Overview

2021–2025

Patent span

Chemistry

Primary field (CPC C)

Patents· 115 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes16%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%

C07KPeptides16%

C12NMicroorganisms or enzymes16%

G01NInvestigating or analysing materials by determining their chemical or physical properties14%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms12%

C12YEnzymes5%

G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology3%

A01NPreservation of bodies of humans or animals or plants or parts thereof3%

C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture1%

PatentTitleYear

12,466,878Peptides and combination of peptides for use in immunotherapy against cancers2025 12,351,616Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers2025 12,295,994Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers2025 12,295,995Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers2025 12,297,254Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers2025 12,295,996Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers2025 12,275,775Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers2025 12,275,776Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers2025 12,258,382Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers2025 12,234,276Uterine cancer treatments2025 12,226,467Peptides and combination of peptides for use in immunotherapy against various cancers2025 12,226,466Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers2025 12,221,626Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers2025 12,221,468Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers2025 12,221,467Uterine cancer treatments2025 12,214,025Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers2025 12,193,998Peptides and combination of peptides for use in immunotherapy against various cancers2025 12,193,997Peptides and combination of peptides for use in immunotherapy against various cancers2025 12,193,999Peptides and combination of peptides for use in immunotherapy against various cancers2025 12,186,276Peptides and combination of peptides for use in immunotherapy against various cancers2025 12,186,277Peptides and combination of peptides for use in immunotherapy against various cancers2025 12,180,259Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers2024 12,180,256Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers2024 12,171,819Peptides and combination of peptides for use in immunotherapy against various cancers2024 12,173,043Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers2024 12,168,044Peptides and combination of peptides for use in immunotherapy against non-small cell lung cancer and other cancers2024 12,168,043Peptides and combination of peptides for use in immunotherapy against various cancers2024 12,156,905CCR8 peptide and T cells for use in immunotherapeutic treatment of various cancers2024 12,150,979Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers2024 12,144,852Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers2024 12,121,572Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers2024 12,102,670Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers2024 12,103,984Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers2024 12,097,248Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers2024 12,097,249Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers2024 12,084,522Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers2024 12,076,381Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers2024 12,076,380Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers2024 12,070,491Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers2024 12,071,458Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers2024 12,059,458Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers2024 12,060,406Peptides and combination of peptides for use in immunotherapy against various tumors2024 12,036,271Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers2024 12,029,785GINS2 peptide and T cells for use in immunotherapeutic treatment of various cancers2024 12,023,372Peptides and T cells for use in immunotherapeutic treatment of various cancers2024 12,018,064Peptides and combination of peptides for use in immunotherapy against various tumors2024 12,005,105Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers2024 12,006,349Peptides and combination of peptides for use in immunotherapy against various tumors2024 11,999,774Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers2024 11,975,058Peptides and T cells for use in immunotherapeutic treatment of various cancers2024 11,965,013Peptides and combination of peptides for use in immunotherapy against various tumors2024 11,957,742Method for treating non-small lung cancer with a population of activated T cells2024 11,951,160Peptides and T cells for use in immunotherapeutic treatment of various cancers2024 11,938,176Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers2024 11,939,366Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers2024 11,932,678Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers2024 11,912,748Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers2024 11,912,749Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers2024 11,905,319Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers2024 11,897,935Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers2024 11,897,934Peptides and combination of peptides for use in immunotherapy against various tumors2024 11,897,936Peptides, combination of peptides as targets and for use in immunotherapy2024 11,873,329Peptides and combination of peptides for use in immunotherapy against various tumors2024 11,833,194Peptides and combination of peptides for use in immunotherapy against various cancers2023 11,826,409Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers2023 11,826,410Peptides and combination of peptides for use in immunotherapy against various cancers2023 11,793,866Peptides and T cells for use in immunotherapeutic treatment of various cancers2023 11,786,583Peptides and combination of peptides for use in immunotherapy against Hepatocellular carcinoma (HCC) and other cancers2023 11,786,584Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers2023 11,779,638Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells2023 11,744,882Peptides and T cells for use in immunotherapeutic treatment of various cancers2023 11,702,460Peptides and combination of peptides for use in immunotherapy against various tumors2023 11,679,147Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells2023 11,672,848Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells2023 11,673,917Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers2023 11,608,370Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers2023 11,597,752Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers2023 11,576,956Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers2023 11,576,954Method for treating non-small lung cancer with a population of activated cells2023 11,559,573Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells2023 11,559,572Peptides and T cells for use in immunotherapeutic treatment of various cancers2023 11,547,750Peptides and T cells for use in immunotherapeutic treatment hepatocellular carcinoma2023 11,541,107Peptides and T cells for use in immunotherapeutic treatment of various cancers2023 11,485,769Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers2022 11,485,765Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers2022 11,479,594Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers2022 11,466,072Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,459,371Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,440,947Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,434,274Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,433,124Peptides and combination of peptides for use in immunotherapy against various cancers2022 11,434,273Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,407,810Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,406,693Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers2022 11,407,808Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,407,809Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,407,807Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,401,310Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers2022 11,401,319Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers2022 11,390,660Uterine cancer treatments2022 11,384,127Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers2022 11,384,128Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers2022 11,384,129Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers2022 11,365,235Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,365,234Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,359,003Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers2022 11,332,512Peptides and combination of peptides for use in immunotherapy against various tumors2022 11,324,812Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers2022 11,260,115Peptides and combination of peptides for use in immunotherapy against CLL and other cancers2022 11,235,041Peptides and combination of peptides for use in immunotherapy against various cancers2022 11,235,042Peptides and combination of peptides for use in immunotherapy against various cancers2022 11,230,581Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers2022 11,224,644Peptides and combination of peptides for use in immunotherapy against various cancers2022 11,180,532Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers2021 11,155,597Relaxin1 derived peptides for use in immunotherapy2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2025Patents assigned to IMMATICS BIOTECHNOLOGIES GMBH (115)· patent assignee history

2021–2025Based in DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
IMMATICS BIOTECHNOLOGIES GMBH	115	2021–2025

Locations

Location	Patents	Span
DE	115	2021–2025